CytomX Therapeutics Inc. (CTMX) slipped -6.4% or -1.62 to $23.7. It is near to 1.08 million shares traded, which is 215.85% compare to the average total volume 500258. The market cap of CTMX is $923.29 million. The year to date change is 9.96%. The 52 week price range is from $13.09 to $35.0. Price of CTMX have changed 0.68% during last week. It have changed 2.63% over last month, -14.69% over last 3 months, 0.60% over last 6 months and 48.16% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTMX is 24.55. It is 3.59% above current price. The 200-day Moving Averages for CTMX is 24.71. It is 4.26% above current price. The 52-week High is 35.0. It is 47.68% from the current price. The 52-week Low is 13.09. It is -44.77% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CTMX is 4.1 on 2018-06-15. Short % to float is 5.32%. There are some statistics of CTMX. It is has market cap $923.29 million. The share outstanding is 38.96 million. The average volume is 500258. The revenue is 32.90M. The percent of top 15 Institution holding is 78.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTMX is -74.55%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTMX is -17.29%.